Cargando…
Human and Epstein-Barr Virus miRNA Profiling as Predictive Biomarkers for Endemic Burkitt Lymphoma
Endemic Burkitt lymphoma (eBL) is an aggressive B cell lymphoma and is associated with Epstein-Barr virus (EBV) and Plasmodium falciparum malaria co-infections. Central to BL oncogenesis is the over-expression of the MYC proto-oncogene which is caused by a translocation of an Ig enhancer in approxim...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5368269/ https://www.ncbi.nlm.nih.gov/pubmed/28400759 http://dx.doi.org/10.3389/fmicb.2017.00501 |
_version_ | 1782517895887060992 |
---|---|
author | Oduor, Cliff I. Movassagh, Mercedeh Kaymaz, Yasin Chelimo, Kiprotich Otieno, Juliana Ong'echa, John M. Moormann, Ann M. Bailey, Jeffrey A. |
author_facet | Oduor, Cliff I. Movassagh, Mercedeh Kaymaz, Yasin Chelimo, Kiprotich Otieno, Juliana Ong'echa, John M. Moormann, Ann M. Bailey, Jeffrey A. |
author_sort | Oduor, Cliff I. |
collection | PubMed |
description | Endemic Burkitt lymphoma (eBL) is an aggressive B cell lymphoma and is associated with Epstein-Barr virus (EBV) and Plasmodium falciparum malaria co-infections. Central to BL oncogenesis is the over-expression of the MYC proto-oncogene which is caused by a translocation of an Ig enhancer in approximation to the myc gene. While whole genome/transcriptome sequencing methods have been used to define driver mutations and transcriptional dysregulation, microRNA (miRNA) dysregulation and differential expression has yet to be fully characterized. We hypothesized that both human and EBV miRNAs contribute to eBL clinical presentation, disease progression, and poor outcomes. Using sensitive and precise deep sequencing, we identified miRNAs from 17 Kenyan eBL patient tumor samples and delineated the complement of both host and EBV miRNAs. One human miRNA, hsa-miR-10a-5p was found to be differentially expressed (DE), being down-regulated in jaw tumors relative to abdominal and in non-survivors compared to survivors. We also examined EBV miRNAs, which made up 2.7% of the miRNA composition in the eBL samples. However, we did not find any significant associations regarding initial patient outcome or anatomical presentation. Gene ontology analysis and pathway enrichment of previously validated targets of miR-10a-5p suggest that it can promote tumor cell survival as well as aid in evasion of apoptosis. To examine miR-10a-5p regulatory effect on gene expression in eBL, we performed a pairwise correlation coefficient analysis on the expression levels of all its validated targets. We found a significant enrichment of correlated target genes consistent with miR-10a-5p impacting expression. The functions of genes and their correlation fit with multiple target genes impacting tumor resilience. The observed downregulation of miR-10a and associated genes suggests a role for miRNA in eBL patient outcomes and has potential as a predictive biomarker that warrants further investigation. |
format | Online Article Text |
id | pubmed-5368269 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-53682692017-04-11 Human and Epstein-Barr Virus miRNA Profiling as Predictive Biomarkers for Endemic Burkitt Lymphoma Oduor, Cliff I. Movassagh, Mercedeh Kaymaz, Yasin Chelimo, Kiprotich Otieno, Juliana Ong'echa, John M. Moormann, Ann M. Bailey, Jeffrey A. Front Microbiol Microbiology Endemic Burkitt lymphoma (eBL) is an aggressive B cell lymphoma and is associated with Epstein-Barr virus (EBV) and Plasmodium falciparum malaria co-infections. Central to BL oncogenesis is the over-expression of the MYC proto-oncogene which is caused by a translocation of an Ig enhancer in approximation to the myc gene. While whole genome/transcriptome sequencing methods have been used to define driver mutations and transcriptional dysregulation, microRNA (miRNA) dysregulation and differential expression has yet to be fully characterized. We hypothesized that both human and EBV miRNAs contribute to eBL clinical presentation, disease progression, and poor outcomes. Using sensitive and precise deep sequencing, we identified miRNAs from 17 Kenyan eBL patient tumor samples and delineated the complement of both host and EBV miRNAs. One human miRNA, hsa-miR-10a-5p was found to be differentially expressed (DE), being down-regulated in jaw tumors relative to abdominal and in non-survivors compared to survivors. We also examined EBV miRNAs, which made up 2.7% of the miRNA composition in the eBL samples. However, we did not find any significant associations regarding initial patient outcome or anatomical presentation. Gene ontology analysis and pathway enrichment of previously validated targets of miR-10a-5p suggest that it can promote tumor cell survival as well as aid in evasion of apoptosis. To examine miR-10a-5p regulatory effect on gene expression in eBL, we performed a pairwise correlation coefficient analysis on the expression levels of all its validated targets. We found a significant enrichment of correlated target genes consistent with miR-10a-5p impacting expression. The functions of genes and their correlation fit with multiple target genes impacting tumor resilience. The observed downregulation of miR-10a and associated genes suggests a role for miRNA in eBL patient outcomes and has potential as a predictive biomarker that warrants further investigation. Frontiers Media S.A. 2017-03-28 /pmc/articles/PMC5368269/ /pubmed/28400759 http://dx.doi.org/10.3389/fmicb.2017.00501 Text en Copyright © 2017 Oduor, Movassagh, Kaymaz, Chelimo, Otieno, Ong'echa, Moormann and Bailey. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Microbiology Oduor, Cliff I. Movassagh, Mercedeh Kaymaz, Yasin Chelimo, Kiprotich Otieno, Juliana Ong'echa, John M. Moormann, Ann M. Bailey, Jeffrey A. Human and Epstein-Barr Virus miRNA Profiling as Predictive Biomarkers for Endemic Burkitt Lymphoma |
title | Human and Epstein-Barr Virus miRNA Profiling as Predictive Biomarkers for Endemic Burkitt Lymphoma |
title_full | Human and Epstein-Barr Virus miRNA Profiling as Predictive Biomarkers for Endemic Burkitt Lymphoma |
title_fullStr | Human and Epstein-Barr Virus miRNA Profiling as Predictive Biomarkers for Endemic Burkitt Lymphoma |
title_full_unstemmed | Human and Epstein-Barr Virus miRNA Profiling as Predictive Biomarkers for Endemic Burkitt Lymphoma |
title_short | Human and Epstein-Barr Virus miRNA Profiling as Predictive Biomarkers for Endemic Burkitt Lymphoma |
title_sort | human and epstein-barr virus mirna profiling as predictive biomarkers for endemic burkitt lymphoma |
topic | Microbiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5368269/ https://www.ncbi.nlm.nih.gov/pubmed/28400759 http://dx.doi.org/10.3389/fmicb.2017.00501 |
work_keys_str_mv | AT oduorcliffi humanandepsteinbarrvirusmirnaprofilingaspredictivebiomarkersforendemicburkittlymphoma AT movassaghmercedeh humanandepsteinbarrvirusmirnaprofilingaspredictivebiomarkersforendemicburkittlymphoma AT kaymazyasin humanandepsteinbarrvirusmirnaprofilingaspredictivebiomarkersforendemicburkittlymphoma AT chelimokiprotich humanandepsteinbarrvirusmirnaprofilingaspredictivebiomarkersforendemicburkittlymphoma AT otienojuliana humanandepsteinbarrvirusmirnaprofilingaspredictivebiomarkersforendemicburkittlymphoma AT ongechajohnm humanandepsteinbarrvirusmirnaprofilingaspredictivebiomarkersforendemicburkittlymphoma AT moormannannm humanandepsteinbarrvirusmirnaprofilingaspredictivebiomarkersforendemicburkittlymphoma AT baileyjeffreya humanandepsteinbarrvirusmirnaprofilingaspredictivebiomarkersforendemicburkittlymphoma |